Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice.

Beck AW, Luster TA, Miller AF, Holloway SE, Conner CR, Barnett CC, Thorpe PE, Fleming JB, Brekken RA.

Int J Cancer. 2006 May 15;118(10):2639-43.

PMID:
16353142
[PubMed - indexed for MEDLINE]
2.

Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.

Bruns CJ, Shrader M, Harbison MT, Portera C, Solorzano CC, Jauch KW, Hicklin DJ, Radinsky R, Ellis LM.

Int J Cancer. 2002 Nov 10;102(2):101-8.

PMID:
12385004
[PubMed - indexed for MEDLINE]
3.

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R.

Clin Cancer Res. 2000 May;6(5):1936-48.

PMID:
10815919
[PubMed - indexed for MEDLINE]
Free Article
4.

Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells.

Luster TA, He J, Huang X, Maiti SN, Schroit AJ, de Groot PG, Thorpe PE.

J Biol Chem. 2006 Oct 6;281(40):29863-71. Epub 2006 Aug 10.

PMID:
16905548
[PubMed - indexed for MEDLINE]
Free Article
5.

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.

Dineen SP, Sullivan LA, Beck AW, Miller AF, Carbon JG, Mamluk R, Wong H, Brekken RA.

BMC Cancer. 2008 Nov 27;8:352. doi: 10.1186/1471-2407-8-352.

PMID:
19038046
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model.

Conrad C, Ischenko I, Köhl G, Wiegand U, Guba M, Yezhelyev M, Ryan AJ, Barge A, Geissler EK, Wedge SR, Jauch KW, Bruns CJ.

Anticancer Drugs. 2007 Jun;18(5):569-79.

PMID:
17414626
[PubMed - indexed for MEDLINE]
7.

Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.

Jia L, Zhang MH, Yuan SZ, Huang WG.

World J Gastroenterol. 2005 Jan 21;11(3):447-50.

PMID:
15637766
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice.

Ran S, He J, Huang X, Soares M, Scothorn D, Thorpe PE.

Clin Cancer Res. 2005 Feb 15;11(4):1551-62.

PMID:
15746060
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer.

Cardillo TM, Blumenthal R, Ying Z, Gold DV.

Int J Cancer. 2002 Jan 20;97(3):386-92.

PMID:
11774294
[PubMed - indexed for MEDLINE]
11.

Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids.

He J, Luster TA, Thorpe PE.

Clin Cancer Res. 2007 Sep 1;13(17):5211-8.

PMID:
17785577
[PubMed - indexed for MEDLINE]
Free Article
12.

Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft.

Gold DV, Modrak DE, Schutsky K, Cardillo TM.

Int J Cancer. 2004 Apr 20;109(4):618-26.

PMID:
14991585
[PubMed - indexed for MEDLINE]
13.

Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.

Zagon IS, Jaglowski JR, Verderame MF, Smith JP, Leure-Dupree AE, McLaughlin PJ.

Cancer Chemother Pharmacol. 2005 Nov;56(5):510-20. Epub 2005 Jun 10.

PMID:
15947928
[PubMed - indexed for MEDLINE]
14.

Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.

Ogura Y, Mizumoto K, Nagai E, Murakami M, Inadome N, Saimura M, Matsumoto K, Nakamura T, Maemondo M, Nukiwa T, Tanaka M.

Cancer Gene Ther. 2006 May;13(5):520-9.

PMID:
16341142
[PubMed - indexed for MEDLINE]
15.

[Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer].

Wang SJ, Sun B, Pan SH, Chen H, Kong R, Li J, Xue DB, Bai XW, Jiang HC.

Zhonghua Wai Ke Za Zhi. 2010 Apr 1;48(7):530-4. Chinese.

PMID:
20646665
[PubMed - indexed for MEDLINE]
16.

K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.

Réjiba S, Wack S, Aprahamian M, Hajri A.

Cancer Sci. 2007 Jul;98(7):1128-36. Epub 2007 May 8.

PMID:
17489984
[PubMed - indexed for MEDLINE]
17.

Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma.

Solorzano CC, Baker CH, Tsan R, Traxler P, Cohen P, Buchdunger E, Killion JJ, Fidler IJ.

Clin Cancer Res. 2001 Aug;7(8):2563-72.

PMID:
11489840
[PubMed - indexed for MEDLINE]
Free Article
18.

Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.

Yezhelyev MV, Koehl G, Guba M, Brabletz T, Jauch KW, Ryan A, Barge A, Green T, Fennell M, Bruns CJ.

Clin Cancer Res. 2004 Dec 1;10(23):8028-36.

PMID:
15585638
[PubMed - indexed for MEDLINE]
Free Article
19.

Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation.

Buchsbaum DJ, Bonner JA, Grizzle WE, Stackhouse MA, Carpenter M, Hicklin DJ, Bohlen P, Raisch KP.

Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1180-93.

PMID:
12419447
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk